Get Full access to Top 1000 data, subscribe from only €29

Register Now »

Ipsen Manufacturing

Ipsen is a biotechnological group aiming to become a leader in specialty healthcare solutions for debilitating diseases. Its strategy is supported by three franchises, neurology, endocrinology and urology-oncology. Ipsen has a growing portfolio in prostate cancer, bladder cancer or neuro-endocrine tumours and a presence in primary care. The group has more than 4,500 employees spread across R&D and manufacturing sites located in China, France, Ireland, the UK and the US.

Financial Data

  • 31st Dec 20 Source: CRO
    • €240.3 million turnover
    • €211.7 million profit
    • 162 employees
  • 31st Dec 19 Source: CRO
    • €212.4 million turnover
    • €188.9 million profit
    • 165 employees


By Turnover

(€240.3 million)

By Employees

299th in Top Companies By Turnover
  • 162
  • €240.3 million


  • Tim Shanahan General Manager

Latest News


Thanks, You are now signed up to the Top 1000 newsletter!